chartexchange

IMVT
Immunovant, Inc. Common Stock
stockNASDAQ

At CloseNov 18, 2026 3:59:59 PM EST
33.19USD-0.060%(-0.02)907,608
Pre-marketNov 18, 2026 8:37:30 AM EST
33.67USD+1.377%(+0.46)
After-hoursNov 18, 2026 4:00:30 PM EST
33.17USD-0.060%(-0.02)
Loading…
Loading…
Healthcare
Biotechnology
HQ
New York, NY, USA
Previous Close
$33.21
Beta
1.59
52-Week High
$45.42 2026-08-19
52-Week Low
$21.86 2025-11-21
SMA 50
$32.39
SMA 200
$32.42
Avg. Vol 10D
1.64M
Avg. Vol 30D
1.46M
Avg. Vol 90D
1.31M
Relative Vol
0.62
206.95M
84.99M
18,550,107
0.2900%
2,500,000
IMVT Profile

immunovant, inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. it develops imvt-1401, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in phase iia clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as has completed initiation of phase ii clinical trials for the treatment of warm autoimmune hemolytic anemia. the company is headquartered in new york, new york. immunovant, inc. is a subsidiary of roivant sciences ltd.

IMVT Performance
PeriodPriceDateChangeBeta
1W37.042026-11-11-10.39%-1.045
1M27.622026-10-19+20.17%2.150
3M44.302026-08-18-25.08%1.806
6M26.532026-05-18+25.10%1.505
1Y23.692025-11-18+40.10%1.587
2Y25.512024-11-18+30.11%—
5Y7.902021-11-18+320.13%1.133
IMVT Stock Summary

Immunovant, Inc. Common Stock (NASDAQ:IMVT) stock price today is $33.19, and today's volume is 907,608. IMVT is down 0.060% today. The 30 day average volume is 1.46M. IMVT market cap is $6.87B with 206.95M shares outstanding.